Multi Vessel Coronary Artery Disease
Cardiovascular
0
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
XeltisCABG
CathWorksFFRangio
AbbottPressureWire Certus guidewire
Clinical Trials (3)
Total enrollment: 242 patients across 3 trials
Xeltis Coronary Artery Bypass Graft (XABG) First in Human (FIH)
Start: Oct 2020Est. completion: Feb 2031
N/AEnrolling By Invitation
Angiogram Based Fractional Flow Reserve in Patients With Multi-Vessel Disease
Start: Nov 2017Est. completion: May 2018
N/ACompleted
Assessing Microvascular Resistance Via IMR To Predict Cumulative Outcome in STEMI Patients Undergoing Primary PCI
Start: Jun 2013Est. completion: Feb 2018242 patients
N/ACompleted
Related Jobs in Cardiovascular
Embedded Software and System Test Engineer (H/F)
Cardiawave
Levallois-Perret, France (Hybrid)
Just now
Territory Sales Manager - Iowa / Nebraska
HeartFlow
Cedar Rapids, IA; Des Moines, IA; Omaha, NE; Lincoln, NE
22h ago
From $150K/yr
Ingénieur d'Application Clinique (H/F) Dept. 54, 57, 67, 68, 25, 90
Johnson & Johnson
Issy-les-Moulineaux, France
23h ago
Trainee Technical Specialist
Johnson & Johnson
Leeds, West Yorkshire, United Kingdom
23h ago
Regional Sales Specialist (Orange County / Long Beach, CA) - Johnson & Johnson MedTech, Electrophysiology
Johnson & Johnson
Irvine, California, United States of America
23h ago
$100K - $135K/yr
Clinical Consultant
Johnson & Johnson
North Ryde, New South Wales, Australia
23h ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space